BioArctic AB (publ)
General ticker "BRCTF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.0B (TTM average)
BioArctic AB (publ) follows the US Stock Market performance with the rate: 43.2%.
Estimated limits based on current volatility of 2.8%: low 33.08$, high 35.01$
Short-term BRCTF quotes
Long-term BRCTF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | SEK616.00MM | SEK257.35MM | SEK1,994.10MM |
| Operating Expenses | SEK363.36MM | SEK485.87MM | SEK629.39MM |
| Operating Income | SEK252.64MM | SEK-228.51MM | SEK1,364.71MM |
| Non-Operating Income | SEK23.85MM | SEK38.99MM | SEK-112.28MM |
| Interest Expense | SEK0.38MM | SEK1.85MM | SEK37.81MM |
| R&D Expense | SEK0.00MM | SEK311.14MM | SEK375.97MM |
| Income(Loss) | SEK276.49MM | SEK-189.52MM | SEK1,252.44MM |
| Taxes | SEK47.24MM | SEK-12.44MM | SEK232.68MM |
| Profit(Loss)* | SEK205.86MM | SEK-125.64MM | SEK1,019.76MM |
| Stockholders Equity | SEK1,046.58MM | SEK894.94MM | SEK1,962.15MM |
| Assets | SEK1,186.08MM | SEK1,111.68MM | SEK2,568.77MM |
| Operating Cash Flow | SEK309.69MM | SEK-316.33MM | SEK1,427.48MM |
| Capital expenditure | SEK7.44MM | SEK26.64MM | SEK1,427.48MM |
| Investing Cash Flow | SEK-507.49MM | SEK205.63MM | SEK-892.41MM |
| Financing Cash Flow | SEK14.06MM | SEK5.69MM | SEK26.84MM |
| Earnings Per Share** | SEK2.33 | SEK-1.42 | SEK11.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.